Coudoré F, Nicolay A, Hoareau M, Eschalier A
Laboratoire de Pharmacologie Clinique et Toxicologie, Centre Hospitalier Universitaire G. Montpied, Clermont-Ferrand, France.
J Anal Toxicol. 1999 May-Jun;23(3):195-9. doi: 10.1093/jat/23.3.195.
A procedure that involves a high-performance liquid chromatographic system with silica-bonded columns and reversed-phase eluents was fitted from a previously described method to measure clozapine and desmethylclozapine plasma levels. Clozapine and its demethylated metabolite were extracted from alkalinized serum by a liquid-liquid extraction, separated in 10 min, then quantitated at 254 nm at a minimum concentration of 20 ng/mL. The standard curves were linear over the range of 50-3000 ng/mL (r > 0.99) both for clozapine and desmethylclozapine and the assay had good sensitivity and recovery. Intra- and interday coefficients of variation for 200 and 800 ng/mL controls were less than 11.5% for clozapine and desmethylclozapine. This simple and efficient assay was used to monitor clozapine and desmethylclozapine levels from some treatment-refractory schizophrenic patients.
一种采用硅胶键合柱和反相洗脱液的高效液相色谱系统的方法,是根据先前描述的方法改编而来,用于测量氯氮平和去甲基氯氮平的血浆水平。氯氮平及其去甲基代谢物通过液液萃取从碱化血清中提取,在10分钟内分离,然后在254nm处进行定量,最低浓度为20ng/mL。氯氮平和去甲基氯氮平的标准曲线在50-3000ng/mL范围内呈线性(r>0.99),该测定法具有良好的灵敏度和回收率。氯氮平和去甲基氯氮平在200和800ng/mL对照品的日内和日间变异系数均小于11.5%。这种简单有效的测定法用于监测一些难治性精神分裂症患者的氯氮平和去甲基氯氮平水平。